Stock A156100 L&K BIOMED LTD.
Add to a list
To use this feature you must be a member
Log inSign up

All News L&K Biomed Ltd.

Equities

A156100

KR7156100000

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-05-15 pm EDT 		5-day change 1st Jan Change
9,330 KRW +2.19% Intraday chart for L&K Biomed Ltd. -0.74% -8.35%
2023 RootLoc Co., Ltd. announced that it has received KRW 3.686515722 billion in funding from L&K Biomed Ltd. CI
2023 RootLoc Co., Ltd. announced that it expects to receive KRW 3.686515722 billion in funding from L&K Biomed Ltd. CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
RootLoc Co., Ltd. announced that it has received KRW 3.686515722 billion in funding from L&K Biomed Ltd.
CI
RootLoc Co., Ltd. announced that it expects to receive KRW 3.686515722 billion in funding from L&K Biomed Ltd.
CI
L&K Biomed to Raise 36.6 Billion Won via Shares Issuance; Shares Plunge 23%
MT
L&K Biomed Ltd.(KOSDAQ:A156100) added to S&P Global BMI Index
CI
L&K Biomed Ltd. announced that it has received KRW 20 billion in funding from NH Investment & Securities Co., Ltd., Asset Management Arm, BNK Securities Co., Ltd., Investment Arm, Core Trend Investment Ltd., Kiwoom Securities Co., Ltd., Investment Arm and other investors
CI
L&K Biomed Ltd. announced that it expects to receive KRW 20 billion in funding from NH Investment & Securities Co., Ltd., Asset Management Arm, BNK Securities Co., Ltd., Investment Arm, Core Trend Investment Ltd., Kiwoom Securities Co., Ltd., Investment Arm and other investors
CI
Tranche Update on L&K Biomed Ltd.'s Equity Buyback Plan announced on May 30, 2017.
CI
Tranche Update on L&K Biomed Ltd.'s Equity Buyback Plan announced on May 30, 2017.
CI
Tranche Update on L&K Biomed Ltd.'s Equity Buyback Plan announced on May 30, 2017.
CI
Tranche Update on L&K Biomed Ltd.'s Equity Buyback Plan announced on May 30, 2017.
CI
Tranche Update on L&K Biomed Ltd.'s Equity Buyback Plan announced on May 30, 2017.
CI
L&K Biomed Ltd.'s Equity Buyback announced on May 30, 2017, has expired with 361,567 shares, representing 3.88% for KRW 2,986.18 million.
CI
L&K Biomed Ltd.'s Equity Buyback Plan Extended till November 30, 2020.
CI
Tranche Update on L&K Biomed Ltd.'s Equity Buyback Plan announced on May 30, 2017.
CI
L&K Biomed Ltd.'s Equity Buyback Plan Extended till November 30, 2019.
CI
Tranche Update on L&K Biomed Ltd.'s Equity Buyback Plan announced on May 30, 2017.
CI
Tranche Update on L&K Biomed Ltd.'s Equity Buyback Plan announced on May 30, 2017.
CI
Tranche Update on L&K Biomed Ltd.'s Equity Buyback Plan announced on May 30, 2017.
CI
L&K Biomed Ltd.'s Equity Buyback Plan Extended till May 31, 2019.
CI
Tranche Update on L&K Biomed Ltd.'s Equity Buyback Plan announced on May 30, 2017.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A156100 Stock
  4. News L&K Biomed Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW